基因組工程市場－全球產業規模、佔有率、趨勢、機會和預測，按技術、交付方式、應用、最終用戶、地區和競爭格局分類，2021-2031年預測

全球基因組工程市場規模預計將從2025年的114.1億美元成長至2031年的284.5億美元，年複合成長率達16.45%。基因組工程是指利用CRISPR-Cas9、TALENs和ZFNs等技術，對生物體的遺傳物質進行精確改造，以插入、刪除或改變DNA序列。該市場的主要驅動力是遺傳性疾病和慢性病盛行率的上升，以及基因組研究領域的大量投資和基因編輯技術在農業和治療領域的應用不斷擴展。

主要市場促進因素

CRISPR 和新一代基因編輯工具的持續進步正在從根本上重塑市場格局，將基因組工程從實驗研究轉變為具有商業可行性的治療方法。首批基於 CRISPR 的鐮狀細胞貧血症和BETA-地中海貧血療法的成功核准和隨後的商業化推廣，便是這一轉變的典型例證。

主要市場挑戰

高昂的治療費用和複雜的報銷模式構成了基因組工程市場成長的重大障礙。基因組藥物的研發涉及資本密集的研發和生產過程，因此必須定價高昂才能回收投資。

主要市場趨勢

人工智慧和機器學習的融合正在從根本上改變基因組設計格局，顯著提升編輯工具的精確度。這些計算技術使研究人員能夠以前所未有的速度預測脫靶效應並最佳化引導RNA序列，從而大幅縮短治療藥物的研發週期。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球基因組工程市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術分類（CRISPR、TALEN、ZFN、反義寡核苷酸、其他）
  • 依交付方式（體外交付與體內交付）
  • 依應用領域（細胞株工程、基因工程、診斷應用、藥物發現與開發、其他）
  • 按最終用戶（製藥和生物技術公司、學術和研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美基因組工程市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲基因組工程市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太基因組工程市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲基因組工程市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲基因組工程市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球基因組工程市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Merck KGaA
• Sangamo Therapeutics, Inc.
• GenScript Biotech Corp
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Precision BioSciences, Inc.
• Horizon Discovery Group plc
• Lonza Group Ltd.
• OriGene Technologies, Inc.
• Transposagen Biopharmaceuticals, Inc.

第16章：策略建議

第17章調查會社について,免責事項

The Global Genome Engineering Market will grow from USD 11.41 Billion in 2025 to USD 28.45 Billion by 2031 at a 16.45% CAGR. Genome engineering is the precise modification of an organism's genetic material using technologies such as CRISPR-Cas9, TALENs, and ZFNs to insert, delete, or alter DNA sequences. The market is primarily driven by the rising prevalence of genetic and chronic diseases, coupled with substantial investments in genomic research and the expanding application of gene editing in agriculture and therapeutics.

Key Market Drivers

Continuous advancements in CRISPR and next-generation editing tools are fundamentally reshaping the market by transitioning genome engineering from experimental research to commercially viable therapeutics. This shift is exemplified by the regulatory success and subsequent commercial rollout of the first CRISPR-based treatments for sickle cell disease and beta-thalassemia. The ability to precisely correct genetic defects ex vivo has validated the clinical utility of these technologies, encouraging rapid adoption across healthcare systems and validating the commercial potential of gene-edited medicines.

Key Market Challenges

The high cost of treatment and the complexity of reimbursement models constitute a substantial barrier to the growth of the genome engineering market. Developing genomic medicines involves capital-intensive research and manufacturing processes which necessitates high pricing to recoup investments. Consequently, these elevated costs place a severe strain on healthcare budgets and insurance providers often limiting patient eligibility and delaying coverage decisions. This financial friction prevents these therapies from reaching a wider patient population, thereby restricting the total addressable market and slowing the revenue generation required to sustain further industry innovation.

Key Market Trends

The integration of artificial intelligence and machine learning is fundamentally altering the genomic design landscape by improving the precision of editing tools. These computational technologies enable researchers to predict off-target effects and optimize guide RNA sequences with unprecedented speed, significantly reducing the timeline for therapeutic development. This convergence of biology and computation is attracting massive investment to support generative models that can design novel biological systems from scratch.

Key Market Players

• Merck KGaA
• Sangamo Therapeutics, Inc.
• GenScript Biotech Corp
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Precision BioSciences, Inc.
• Horizon Discovery Group plc
• Lonza Group Ltd.
• OriGene Technologies, Inc.
• Transposagen Biopharmaceuticals, Inc.

Report Scope:

In this report, the Global Genome Engineering Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genome Engineering Market, By Technology:

• CRISPR
• TALEN
• ZFN
• Antisense
• Others

Genome Engineering Market, By Delivery Method:

• Ex-Vivo v/s In-Vivo

Genome Engineering Market, By Application:

• Cell Line Engineering
• Genetic Engineering
• Diagnostic Applications
• Drug Discovery & Development
• Others

Genome Engineering Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Others

Genome Engineering Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Genome Engineering Market.

Available Customizations:

Global Genome Engineering Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genome Engineering Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (CRISPR, TALEN, ZFN, Antisense, Others)
  • 5.2.2. By Delivery Method (Ex-Vivo v/s In-Vivo)
  • 5.2.3. By Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Others)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Genome Engineering Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Delivery Method
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Genome Engineering Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Delivery Method
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Genome Engineering Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Delivery Method
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Genome Engineering Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Delivery Method
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Genome Engineering Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Delivery Method
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Genome Engineering Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Delivery Method
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Genome Engineering Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Delivery Method
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Genome Engineering Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Delivery Method
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Genome Engineering Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Delivery Method
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Genome Engineering Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Delivery Method
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Genome Engineering Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Delivery Method
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Genome Engineering Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Delivery Method
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Genome Engineering Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Delivery Method
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Genome Engineering Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Delivery Method
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Genome Engineering Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Delivery Method
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Genome Engineering Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Delivery Method
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Genome Engineering Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Delivery Method
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Genome Engineering Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Delivery Method
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Genome Engineering Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Delivery Method
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Genome Engineering Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Delivery Method
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Genome Engineering Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Delivery Method
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Genome Engineering Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Delivery Method
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Genome Engineering Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Delivery Method
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Genome Engineering Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Delivery Method
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Genome Engineering Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sangamo Therapeutics, Inc.
• 15.3. GenScript Biotech Corp
• 15.4. CRISPR Therapeutics AG
• 15.5. Editas Medicine, Inc.
• 15.6. Precision BioSciences, Inc.
• 15.7. Horizon Discovery Group plc
• 15.8. Lonza Group Ltd.
• 15.9. OriGene Technologies, Inc.
• 15.10. Transposagen Biopharmaceuticals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer